5 Best Small-Cap Healthcare Stocks To Buy Now

1. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Number of Hedge Fund Holders: 34

Market Capitalization as of December 12: $1.957 Billion

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is a North Carolina-based biotechnology company that discovers novel, oral, and small-molecule medicines. It is one of the best healthcare stocks to monitor. On November 1, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) reported a Q3 revenue of $75.8 million, up 84.9% year-over-year and beating market estimates by $1.02 million. Cash, cash equivalents, restricted cash, and investments came in at $462.6 million on September 30, 2022, compared to $203.9 million on September 30, 2021.

On November 2, Evercore ISI analyst Liisa Bayko upgraded BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) to Outperform from In Line with a price target of $16, up from $14. The stock traded 11% lower after the company’s “sluggish quarter,” but the analyst sees this as an opportunity to buy the dip given the view that Orladeyo’s long-term prospects are intact despite some “short-term blips in numbers.” 

According to Insider Monkey’s data, 34 hedge funds were bullish on BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) at the end of Q3 2022, compared to 31 funds in the earlier quarter. Julian Baker and Felix Baker’s Baker Bros. Advisors is the biggest position holder in the company, with 12.7 million shares worth $160 million.

You can also take a look at Most Advanced Countries in Artificial Intelligence and 11 Best ADR Stocks To Buy.